Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.64 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.72.
Market Cap
9.64T
Revenue
4.66T
Profits
186.45B
PE Ratio
51.72
Profit Margin
4.00%
Dividend Yield
0.37%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.13T | 1.91% | 889,361 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.95B | 1.49% | 1,857,720 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 469.81B | 1.54% | 1,578,944 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 379.30B | 3.19% | 6,006,786 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 351.14B | 1.65% | 1,512,902 | 450.53B |
| 6 | NVS | Novartis AG | 300.60B | 1.81% | 441,654 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 255.77B | 1.40% | 872,699 | 61.37B |
| 8 | AMGN | Amgen Inc. | 237.33B | 1.21% | 656,840 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 232.00B | -0.01% | 507,443 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 204.73B | 2.02% | 4,704,706 | 50.34B |
| 11 | ABT | Abbott Laboratories | 200.93B | 1.73% | 2,645,836 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 182.51B | 2.61% | 1,440,428 | 30.46B |
| 13 | PFE | Pfizer Inc. | 161.02B | 1.66% | 12,481,015 | 63.70B |
| 14 | DHR | Danaher Corporation | 153.76B | 1.31% | 1,598,543 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 139.79B | 2.08% | 355,009 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 137.54B | 2.84% | 3,756,297 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 134.36B | 1.56% | 799,946 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.77B | 0.86% | 1,134,957 | 25.84B |
| 19 | CVS | CVS Health Corporation | 119.39B | -0.33% | 1,450,630 | 412.65B |
| 20 | MDT | Medtronic plc | 119.20B | 0.90% | 2,122,469 | 36.36B |
| 21 | SNY | Sanofi | 108.85B | 1.95% | 663,570 | 55.89B |
| 22 | GSK | GSK plc | 104.98B | 0.62% | 878,996 | 44.05B |
| 23 | MCK | McKesson Corporation | 100.42B | 2.69% | 244,453 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 93.13B | 5.88% | 741,553 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.29B | 1.57% | 172,301 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 84.08B | 1.86% | 333,899 | 15.53B |
| 27 | CI | The Cigna Group | 73.58B | 1.48% | 377,199 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 73.53B | 2.77% | 11,776,906 | 21.00B |
| 29 | ARGX | argenx SE | 64.66B | 1.48% | 91,796 | 5.32B |
| 30 | COR | Cencora, Inc. | 60.94B | 1.48% | 385,044 | 332.77B |
| 31 | MRNA | Moderna, Inc. | 59.09B | 11.02% | 44,472,827 | 2.23B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 57.97B | 0.39% | 537,857 | 28.42B |
| 33 | CAH | Cardinal Health, Inc. | 53.51B | 0.71% | 282,248 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 52.09B | 1.92% | 578,272 | 22.48B |
| 35 | EW | Edwards Lifesciences Corporation | 52.00B | 0.43% | 734,296 | 6.51B |
| 36 | NTRA | Natera, Inc. | 47.18B | 0.77% | 335,679 | 2.71B |
| 37 | HUM | Humana Inc. | 45.82B | 0.22% | 240,509 | 145.68B |
| 38 | A | Agilent Technologies, Inc. | 44.91B | 1.73% | 794,042 | 7.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.79B | -1.31% | 336,730 | - |
| 40 | MDLN | Medline Inc. | 44.51B | 3.91% | 2,059,670 | 29.94B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 43.89B | 2.31% | 958,125 | 17.32B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 43.53B | 1.23% | 164,197 | 4.55B |
| 43 | HLN | Haleon plc | 43.25B | 0.71% | 2,728,971 | 14.80B |
| 44 | ONC | BeOne Medicines AG | 42.97B | 2.38% | 89,015 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 42.82B | 1.61% | 454,605 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 40.43B | -0.67% | 335,192 | 3.32B |
| 47 | WAT | Waters Corporation | 40.19B | 1.09% | 271,727 | 4.64B |
| 48 | ALC | Alcon Inc. | 35.87B | 0.73% | 366,691 | 10.86B |
| 49 | RPRX | Royalty Pharma plc | 35.17B | 0.97% | 725,580 | 2.54B |
| 50 | DXCM | DexCom, Inc. | 34.27B | 0.65% | 731,960 | 4.97B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 33.71B | 0.77% | 545,532 | 21.27B |
| 52 | RMD | ResMed Inc. | 33.66B | 2.15% | 285,122 | 5.65B |
| 53 | ILMN | Illumina, Inc. | 32.71B | 1.58% | 460,651 | 4.49B |
| 54 | BIIB | Biogen Inc. | 32.34B | 2.10% | 185,342 | 10.03B |
| 55 | ZTS | Zoetis Inc. | 32.21B | 3.91% | 1,776,968 | 9.53B |
| 56 | CNC | Centene Corporation | 32.02B | 1.06% | 770,477 | 180.30B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.72B | 3.38% | 546,131 | 4.80B |
| 58 | BNTX | BioNTech SE | 29.62B | 6.32% | 1,455,102 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.04B | 0.45% | 71,916 | 4.13B |
| 60 | INSM | Insmed Incorporated | 27.69B | 1.38% | 214,828 | 1.14B |
| 61 | LH | Labcorp Holdings Inc. | 27.19B | 0.72% | 130,999 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 27.09B | -0.07% | 211,672 | 20.18B |
| 63 | DGX | Quest Diagnostics Incorporated | 26.85B | 0.80% | 249,824 | 11.56B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.39B | -0.81% | 943,072 | 7.53M |
| 65 | INCY | Incyte Corporation | 26.13B | 1.33% | 322,649 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.92B | 0.11% | 137,739 | 3.33B |
| 67 | STE | STERIS plc | 23.19B | 0.88% | 106,955 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.63B | 0.46% | 574,093 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 22.47B | 2.39% | 137,532 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 22.43B | 0.37% | 114,671 | 3.15B |
| 71 | GMAB | Genmab A/S | 19.98B | 0.87% | 1,063,005 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.11B | 1.25% | 227,081 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.63B | 0.62% | 1,393,909 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.33B | 1.36% | 60,033 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.76B | 0.18% | 96,988 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.43B | 1.75% | 118,253 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.15B | -0.41% | 337,160 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.62B | 0.46% | 290,783 | 3.37B |
| 79 | SOLV | Solventum Corporation | 15.12B | 0.26% | 226,944 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.86B | 0.03% | 223,549 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.10B | 1.37% | 235,007 | 4.00B |
| 82 | RVTY | Revvity, Inc. | 13.78B | -0.52% | 492,712 | 2.91B |
| 83 | BAX | Baxter International Inc. | 13.62B | -0.23% | 1,031,037 | 11.47B |
| 84 | ICLR | ICON Public Limited Company | 13.52B | 0.57% | 66,284 | 8.29B |
| 85 | EXEL | Exelixis, Inc. | 13.51B | 1.56% | 258,260 | 2.44B |
| 86 | CORT | Corcept Therapeutics Incorporated | 13.22B | 1.04% | 146,285 | 830.81M |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 13.08B | -0.15% | 352,259 | 3.41B |
| 88 | PEN | Penumbra, Inc. | 12.80B | 0.39% | 62,851 | 1.50B |
| 89 | FMS | Fresenius Medical Care AG | 12.66B | 0.32% | 285,249 | 22.19B |
| 90 | TEM | Tempus AI, Inc. | 12.50B | 3.93% | 6,088,395 | 1.43B |
| 91 | SNN | Smith & Nephew plc | 12.32B | 0.41% | 408,554 | 6.30B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 12.31B | -0.71% | 236,963 | 14.37B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.29B | -0.54% | 191,363 | 669.50M |
| 94 | HALO | Halozyme Therapeutics, Inc. | 12.23B | 1.55% | 264,500 | 1.66B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.18B | 1.60% | 31,269 | 1.28B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.97B | 1.72% | 1,006,766 | 5.02B |
| 97 | EHC | Encompass Health Corporation | 11.95B | 0.15% | 178,235 | 6.21B |
| 98 | GMED | Globus Medical, Inc. | 11.61B | 0.91% | 157,059 | 3.14B |
| 99 | TECH | Bio-Techne Corporation | 11.34B | 0.03% | 1,773,391 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 11.29B | -0.03% | 182,613 | 4.14B |
| 101 | DVA | DaVita Inc. | 11.21B | 0.30% | 127,652 | 14.01B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 11.00B | 0.90% | 151,721 | 776.57M |
| 103 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 10.95B | 0.15% | 245,338 | 5.67M |
| 104 | GKOS | Glaukos Corporation | 10.91B | 0.06% | 86,581 | 612.84M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.78B | 0.44% | 232,250 | 67.67M |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 10.55B | 3.67% | 147,094 | 7.46M |
| 107 | MOH | Molina Healthcare, Inc. | 10.53B | 2.66% | 120,034 | 42.47B |
| 108 | SMMT | Summit Therapeutics Inc. | 10.50B | 5.87% | 2,792,855 | - |
| 109 | UHS | Universal Health Services, Inc. | 10.41B | 2.20% | 98,506 | 18.11B |
| 110 | ENSG | The Ensign Group, Inc. | 10.37B | -0.23% | 52,896 | 5.49B |
| 111 | PODD | Insulet Corporation | 10.32B | 1.28% | 282,716 | 3.05B |
| 112 | KYMR | Kymera Therapeutics, Inc. | 10.27B | 1.70% | 97,944 | 105.00M |
| 113 | RDY | Dr. Reddy's Laboratories Limited | 10.23B | 0.54% | 392,165 | 3.50B |
| 114 | RGEN | Repligen Corporation | 10.19B | 0.17% | 227,229 | 785.10M |
| 115 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.03% | 245,226 | - |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 10.15B | 0.79% | 52,826 | 2.59B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 10.05B | 2.94% | 626,069 | 874.09M |
| 118 | KRYS | Krystal Biotech, Inc. | 10.00B | 0.29% | 33,856 | 440.48M |
| 119 | HSIC | Henry Schein, Inc. | 9.88B | 0.21% | 179,000 | 13.60B |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.83B | 0.77% | 104,770 | 281.99M |
| 121 | AVTR | Avantor, Inc. | 9.75B | 1.19% | 1,312,958 | 6.56B |
| 122 | OSCR | Oscar Health, Inc. | 9.62B | -1.12% | 1,162,075 | 15.32B |
| 123 | SYRE | Spyre Therapeutics, Inc. | 9.52B | 0.19% | 172,167 | - |
| 124 | PCVX | Vaxcyte, Inc. | 9.44B | 3.47% | 345,149 | - |
| 125 | IMVT | Immunovant, Inc. | 9.22B | 0.61% | 189,619 | - |
| 126 | BRKR | Bruker Corporation | 9.14B | 0.07% | 1,034,332 | 3.50B |
| 127 | QGEN | Qiagen N.V. | 9.07B | -2.29% | 893,417 | 2.10B |
| 128 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.03% | 244,895 | 42.16M |
| 129 | TWST | Twist Bioscience Corporation | 8.91B | 4.27% | 524,061 | 431.80M |
| 130 | HQY | HealthEquity, Inc. | 8.79B | 0.82% | 234,958 | 1.34B |
| 131 | ATR | AptarGroup, Inc. | 8.54B | 1.03% | 54,605 | 3.93B |
| 132 | TXG | 10x Genomics, Inc. | 8.38B | 0.75% | 823,323 | 616.91M |
| 133 | IBRX | ImmunityBio, Inc. | 8.28B | -0.32% | 2,526,809 | 165.79M |
| 134 | ALKS | Alkermes plc | 8.11B | 0.69% | 160,753 | 1.67B |
| 135 | TGTX | TG Therapeutics, Inc. | 7.82B | 8.97% | 2,518,800 | 799.54M |
| 136 | HIMS | Hims & Hers Health, Inc. | 7.79B | 4.74% | 4,373,210 | 2.58B |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.53B | 0.45% | 170,743 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.23B | 4.07% | 2,268,358 | 989.61M |
| 139 | ORKA | Oruka Therapeutics, Inc. | 7.14B | 2.90% | 200,261 | - |
| 140 | HNGE | Hinge Health, Inc. | 7.05B | 2.04% | 548,874 | 720.06M |
| 141 | GRFS | Grifols, S.A. | 7.03B | 0.75% | 60,133 | 8.48B |
| 142 | CHE | Chemed Corporation | 6.97B | 0.15% | 28,482 | 2.60B |
| 143 | CGON | CG Oncology, Inc. | 6.91B | 0.49% | 100,152 | 6.23M |
| 144 | PACS | PACS Group, Inc. | 6.90B | -0.02% | 127,375 | 5.55B |
| 145 | SRRK | Scholar Rock Holding Corporation | 6.81B | 1.19% | 334,951 | - |
| 146 | BLTE | Belite Bio, Inc | 6.58B | 0.88% | 16,803 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.54B | -0.09% | 174,138 | 1.56B |
| 148 | COGT | Cogent Biosciences, Inc. | 6.33B | 3.34% | 827,877 | - |
| 149 | LQDA | Liquidia Corporation | 6.28B | -1.29% | 469,060 | 450.91M |
| 150 | DNTH | Dianthus Therapeutics, Inc. | 6.21B | 1.31% | 266,962 | 1.90M |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.20B | -1.64% | 176,753 | 618.07M |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.19B | 1.16% | 74,689 | 840.85M |
| 153 | ERAS | Erasca, Inc. | 6.18B | 3.51% | 735,711 | - |
| 154 | BLCO | Bausch + Lomb Corporation | 6.18B | 0.64% | 42,469 | 5.32B |
| 155 | TVTX | Travere Therapeutics, Inc. | 6.18B | 1.63% | 331,622 | 591.33M |
| 156 | STVN | Stevanato Group S.p.A. | 6.17B | 1.03% | 107,086 | 1.40B |
| 157 | DFTX | Definium Therapeutics, Inc. | 6.08B | -0.35% | 456,014 | - |
| 158 | RDNT | RadNet, Inc. | 6.05B | -0.18% | 193,416 | 2.27B |
| 159 | CRSP | CRISPR Therapeutics AG | 5.98B | 6.33% | 1,262,977 | 13.39M |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.90B | 0.23% | 113,994 | 1.01B |
| 161 | XENE | Xenon Pharmaceuticals Inc. | 5.89B | 1.86% | 271,729 | 7.50M |
| 162 | TFX | Teleflex Incorporated | 5.79B | 1.33% | 76,420 | 2.25B |
| 163 | AMRX | Amneal Pharmaceuticals, Inc. | 5.78B | 1.12% | 224,774 | 3.12B |
| 164 | MMED | MiniMed Group, Inc. | 5.76B | 1.64% | 284,511 | 3.10B |
| 165 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | -0.36% | 32,480 | 290.54M |
| 166 | SHC | Sotera Health Company | 5.51B | 0.52% | 290,529 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.38B | -0.10% | 109,698 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.04B | 0.79% | 270,946 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.96B | 2.19% | 229,331 | - |
| 170 | HAE | Haemonetics Corporation | 4.95B | 0.49% | 152,677 | 1.35B |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.87B | -0.43% | 56,068 | 148.00K |
| 172 | LFST | LifeStance Health Group, Inc. | 4.80B | -0.67% | 376,443 | 1.58B |
| 173 | WAY | Waystar Holding Corp. | 4.77B | 0.12% | 666,719 | 1.21B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.71B | 0.25% | 182,452 | - |
| 175 | CELC | Celcuity Inc. | 4.57B | 3.15% | 182,027 | - |
| 176 | BLLN | BillionToOne, Inc. | 4.56B | 1.48% | 203,157 | 397.41M |
| 177 | DOCS | Doximity, Inc. | 4.55B | -1.50% | 582,281 | 655.57M |
| 178 | ICUI | ICU Medical, Inc. | 4.55B | -0.30% | 60,425 | 2.16B |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 0.37% | 102,510 | 2.29B |
| 180 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.45B | 0.81% | 1,351,912 | -665.00K |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.45B | -0.24% | 356,497 | 1.33B |
| 182 | MANE | Veradermics, Incorporated | 4.45B | 1.06% | 97,314 | - |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.33B | 0.41% | 702,521 | 10.35M |
| 184 | LIVN | LivaNova PLC | 4.33B | 0.45% | 85,225 | 1.47B |
| 185 | HTFL | HeartFlow, Inc. | 4.32B | 6.26% | 548,057 | 212.07M |
| 186 | ELVN | Enliven Therapeutics, Inc. | 4.32B | 0.15% | 250,005 | - |
| 187 | NVST | Envista Holdings Corporation | 4.32B | -0.07% | 674,423 | 2.86B |
| 188 | LEGN | Legend Biotech Corporation | 4.30B | 4.28% | 350,373 | 1.27B |
| 189 | ITGR | Integer Holdings Corporation | 4.26B | 0.11% | 414,429 | 1.84B |
| 190 | IRTC | iRhythm Holdings, Inc. | 4.18B | -1.03% | 85,419 | 825.34M |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | 0.59% | 526,744 | 308.08M |
| 192 | VKTX | Viking Therapeutics, Inc. | 4.03B | 0.44% | 351,935 | - |
| 193 | TNGX | Tango Therapeutics, Inc. | 4.00B | 0.89% | 526,062 | 53.81M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.98B | -0.22% | 159,093 | 3.60M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.88B | 2.74% | 328,578 | 234.13M |
| 196 | IOVA | Iovance Biotherapeutics, Inc. | 3.84B | -5.67% | 12,631,293 | 324.97M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.83B | 1.86% | 106,069 | 117.00M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.78B | -8.70% | 163,027 | 890.79M |
| 199 | ABCL | AbCellera Biologics Inc. | 3.73B | -0.48% | 1,386,325 | 66.17M |
| 200 | NHC | National HealthCare Corporation | 3.63B | -2.15% | 34,575 | 1.56B |
| 201 | OGN | Organon & Co. | 3.61B | -0.04% | 308,230 | 6.13B |
| 202 | OPCH | Option Care Health, Inc. | 3.58B | 1.87% | 292,567 | 5.69B |
| 203 | GPCR | Structure Therapeutics Inc. | 3.58B | -0.68% | 144,566 | - |
| 204 | PLSE | Pulse Biosciences, Inc. | 3.51B | 2.76% | 117,998 | 1.19M |
| 205 | GRAL | GRAIL, Inc. | 3.48B | 0.06% | 183,773 | 165.26M |
| 206 | QURE | uniQure N.V. | 3.41B | 0.54% | 223,466 | 18.67M |
| 207 | WRBY | Warby Parker Inc. | 3.41B | 0.33% | 434,257 | 911.61M |
| 208 | VCYT | Veracyte, Inc. | 3.38B | 0.74% | 181,973 | 561.90M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.32B | -0.11% | 126,707 | 7.12M |
| 210 | IMNM | Immunome, Inc. | 3.27B | 2.60% | 197,436 | 4.02M |
| 211 | TMDX | TransMedics Group, Inc. | 3.25B | 3.16% | 184,598 | 668.47M |
| 212 | CLDX | Celldex Therapeutics, Inc. | 3.22B | 2.57% | 344,442 | 158.00K |
| 213 | MBX | MBX Biosciences, Inc. | 3.20B | 0.11% | 85,477 | - |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.19B | 1.78% | 149,583 | 606.33M |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.12B | -1.93% | 436,544 | 463.98M |
| 216 | IRON | Disc Medicine, Inc. | 3.02B | -0.23% | 89,983 | - |
| 217 | BEAM | Beam Therapeutics Inc. | 2.99B | 5.32% | 1,162,847 | 156.04M |
| 218 | ALMS | Alumis Inc. | 2.96B | -0.13% | 205,001 | 7.40M |
| 219 | ZLAB | Zai Lab Limited | 2.91B | -0.52% | 289,504 | 449.61M |
| 220 | SLS | SELLAS Life Sciences Group, Inc. | 2.90B | 7.01% | 3,819,357 | - |
| 221 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | 1.85% | 3,888,708 | 2.60B |
| 222 | BKD | Brookdale Senior Living Inc. | 2.83B | 0.51% | 791,700 | 2.93B |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.81B | 0.26% | 415,852 | 36.77M |
| 224 | VRDN | Viridian Therapeutics, Inc. | 2.77B | -0.24% | 193,249 | 71.13M |
| 225 | ATAI | AtaiBeckley Inc. | 2.76B | 0.20% | 1,541,988 | 4.47M |
| 226 | ALHC | Alignment Healthcare, Inc. | 2.73B | 1.78% | 538,455 | 4.58B |
| 227 | SUPN | Supernus Pharmaceuticals, Inc. | 2.73B | -1.05% | 132,345 | 830.44M |
| 228 | PRVA | Privia Health Group, Inc. | 2.71B | 0.19% | 106,565 | 2.36B |
| 229 | RGC | Regencell Bioscience Holdings Limited | 2.66B | -1.29% | 69,976 | - |
| 230 | AXGN | Axogen, Inc. | 2.65B | 5.94% | 186,661 | 251.17M |
| 231 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 4.42% | 842,365 | 717.00M |
| 232 | TRVI | Trevi Therapeutics, Inc. | 2.58B | -0.74% | 208,177 | - |
| 233 | PGEN | Precigen, Inc. | 2.57B | -3.63% | 1,355,190 | 85.72M |
| 234 | NEOG | Neogen Corporation | 2.57B | -0.55% | 298,728 | 870.40M |
| 235 | NKTR | Nektar Therapeutics | 2.55B | 0.34% | 176,035 | 54.59M |
| 236 | PHVS | Pharvaris N.V. | 2.55B | -0.11% | 82,391 | - |
| 237 | BHC | Bausch Health Companies Inc. | 2.55B | 0.15% | 438,084 | 10.85B |
| 238 | ACHC | Acadia Healthcare Company, Inc. | 2.54B | 1.11% | 189,940 | 3.37B |
| 239 | WGS | GeneDx Holdings Corp. | 2.51B | 2.06% | 122,864 | 454.43M |
| 240 | ALMR | Alamar Biosciences, Inc. | 2.48B | 3.12% | 62,001 | 100.42M |
| 241 | NUVB | Nuvation Bio Inc. | 2.48B | 3.22% | 2,243,573 | 169.90M |
| 242 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.47B | 0.26% | 559,258 | 940.61M |
| 243 | OCUL | Ocular Therapeutix, Inc. | 2.47B | 1.53% | 475,083 | 52.06M |
| 244 | KOD | Kodiak Sciences Inc. | 2.46B | -1.56% | 166,072 | - |
| 245 | CDNA | CareDx, Inc. | 2.45B | 0.87% | 186,276 | 458.09M |
| 246 | BFLY | Butterfly Network, Inc. | 2.45B | 0.33% | 1,595,080 | 112.14M |
| 247 | ATRC | AtriCure, Inc. | 2.45B | 1.35% | 64,614 | 569.62M |
| 248 | PBH | Prestige Consumer Healthcare Inc. | 2.40B | 0.34% | 45,069 | 1.10B |
| 249 | UFPT | UFP Technologies, Inc. | 2.38B | 0.79% | 48,751 | 631.64M |
| 250 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | -0.43% | 56,077 | 1.46B |
| 251 | VERA | Vera Therapeutics, Inc. | 2.33B | 3.49% | 443,573 | - |
| 252 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | 1.48% | 191,077 | - |
| 253 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 1.66% | 144,284 | - |
| 254 | RAPP | Rapport Therapeutics, Inc. | 2.29B | -0.44% | 32,243 | 20.00M |
| 255 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.26B | 5.19% | 2,923,587 | 208.78M |
| 256 | URGN | UroGen Pharma Ltd. | 2.26B | -1.15% | 215,944 | 188.73M |
| 257 | KLRA | Kailera Therapeutics, Inc. | 2.26B | -0.29% | 82,757 | - |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | -1.85% | 343,644 | 311.51M |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 1.02% | 110,756 | 959.90M |
| 260 | NBTX | Nanobiotix S.A. | 2.22B | 0.64% | 30,901 | 38.27M |
| 261 | ADUS | Addus HomeCare Corporation | 2.21B | 0.39% | 60,520 | 1.48B |
| 262 | ADMA | ADMA Biologics, Inc. | 2.21B | 0.92% | 400,592 | 512.28M |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | 2.41% | 1,094,812 | 3.64B |
| 264 | CLOV | Clover Health Investments, Corp. | 2.20B | 0.98% | 989,296 | 2.48B |
| 265 | MESO | Mesoblast Limited | 2.18B | -2.70% | 83,311 | 65.38M |
| 266 | VCEL | Vericel Corporation | 2.18B | 1.23% | 135,618 | 306.30M |
| 267 | HCM | HUTCHMED (China) Limited | 2.16B | 0.32% | 3,261 | 549.12M |
| 268 | NEO | NeoGenomics, Inc. | 2.14B | 0.76% | 263,465 | 766.30M |
| 269 | ESTA | Establishment Labs Holdings Inc. | 2.13B | 0.06% | 90,361 | 245.82M |
| 270 | BHVN | Biohaven Ltd. | 2.11B | 3.63% | 466,296 | - |
| 271 | ZBIO | Zenas BioPharma, Inc. | 2.10B | 1.80% | 133,735 | 1.00M |
| 272 | MD | Pediatrix Medical Group, Inc. | 2.09B | 0.42% | 150,393 | 1.95B |
| 273 | GENB | Generate Biomedicines, Inc. | 2.08B | 1.44% | 276,031 | 26.48M |
| 274 | STOK | Stoke Therapeutics, Inc. | 2.07B | 2.39% | 129,795 | 27.59M |
| 275 | XNCR | Xencor, Inc. | 2.06B | 2.78% | 214,752 | 104.97M |
| 276 | PVLA | Palvella Therapeutics, Inc. | 2.05B | 0.01% | 35,091 | - |
| 277 | SRPT | Sarepta Therapeutics, Inc. | 2.05B | 1.20% | 344,620 | 1.97B |
| 278 | NVCR | NovoCure Limited | 2.04B | -1.29% | 241,912 | 699.19M |
| 279 | TRLV | Trulieve Cannabis Corp. | 2.03B | 2.73% | 481,457 | 1.14B |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | -0.09% | 101,074 | 98.34M |
| 281 | PSNL | Personalis, Inc. | 1.99B | 10.37% | 2,577,557 | 69.67M |
| 282 | ASTH | Astrana Health, Inc. | 1.98B | -0.06% | 48,810 | 3.84B |
| 283 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | -0.49% | 362,884 | 5.49M |
| 284 | PGNY | Progyny, Inc. | 1.98B | -0.54% | 172,891 | 1.31B |
| 285 | KARD | Kardigan, Inc. | 1.96B | 3.60% | 43,848 | - |
| 286 | GHRS | GH Research PLC | 1.96B | -0.35% | 27,338 | - |
| 287 | ZYME | Zymeworks Inc. | 1.94B | 2.82% | 115,465 | 37.13M |
| 288 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.05% | 990,254 | - |
| 289 | PRGO | Perrigo Company plc | 1.92B | 0.95% | 294,864 | 4.14B |
| 290 | DMRA | Damora Therapeutics, Inc. | 1.91B | 2.31% | 30,719 | - |
| 291 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 6.74% | 11,513,594 | 54.86M |
| 292 | CMPS | COMPASS Pathways plc | 1.91B | -0.22% | 558,280 | - |
| 293 | IMCR | Immunocore Holdings plc | 1.90B | 1.65% | 81,744 | 430.78M |
| 294 | SEPN | Septerna, Inc. | 1.89B | -0.61% | 68,867 | 98.88M |
| 295 | LMAT | LeMaitre Vascular, Inc. | 1.89B | 0.26% | 62,338 | 262.43M |
| 296 | LKFT | Lakefront Biotherapeutics NV | 1.87B | 2.44% | 100,436 | 1.13B |
| 297 | SNDA | Sonida Senior Living, Inc. | 1.86B | 0.15% | 90,715 | 481.07M |
| 298 | SGRY | Surgery Partners, Inc. | 1.82B | 0.86% | 465,836 | 3.37B |
| 299 | INSP | Inspire Medical Systems, Inc. | 1.82B | 2.51% | 94,709 | 898.74M |
| 300 | NTLA | Intellia Therapeutics, Inc. | 1.81B | 4.02% | 1,303,662 | 59.51M |
| 301 | BLFS | BioLife Solutions, Inc. | 1.80B | -0.22% | 187,633 | 106.69M |
| 302 | BRVE | Braveheart Bio, Inc. | 1.78B | 1.33% | 27,927 | - |
| 303 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | 0.61% | 202,820 | 252.25M |
| 304 | ETON | Eton Pharmaceuticals, Inc. | 1.75B | 2.24% | 127,386 | 105.60M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.72B | -0.38% | 137,010 | 2.68B |
| 306 | ANAB | AnaptysBio, Inc. | 1.70B | 1.36% | 82,102 | 232.39M |
| 307 | ABSI | Absci Corporation | 1.68B | 5.28% | 989,023 | 1.56M |
| 308 | AVLN | Avalyn Pharma Inc. | 1.67B | 1.59% | 37,619 | - |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.64B | -0.97% | 46,711 | 978.38M |
| 310 | VIR | Vir Biotechnology, Inc. | 1.63B | 4.83% | 343,125 | 303.23M |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.63B | 1.31% | 44,675 | 20.00M |
| 312 | OMCL | Omnicell, Inc. | 1.62B | 0.31% | 172,427 | 1.25B |
| 313 | AZTA | Azenta, Inc. | 1.61B | 0.82% | 121,454 | 613.81M |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.60B | -1.03% | 242,729 | - |
| 315 | TYRA | Tyra Biosciences, Inc. | 1.59B | 3.50% | 74,783 | - |
| 316 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 1.16% | 353,370 | 335.41M |
| 317 | ALVO | Alvotech | 1.58B | 3.98% | 547,612 | 494.61M |
| 318 | KMTS | Kestra Medical Technologies, Ltd. | 1.58B | -0.81% | 119,395 | 95.13M |
| 319 | FRNM | Freenome, Inc. | 1.58B | 3.63% | 269,124 | 34.24M |
| 320 | AGL | agilon health, inc. | 1.56B | 0.14% | 48,934 | 5.92B |
| 321 | HROW | Harrow, Inc. | 1.56B | -1.13% | 116,206 | 275.59M |
| 322 | TNDM | Tandem Diabetes Care, Inc. | 1.56B | -0.84% | 269,525 | 1.04B |
| 323 | SLBT | SL Science Holding Limited | 1.56B | 0.74% | 8,968 | 3.27M |
| 324 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | 3.84% | 153,638 | - |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.55B | -1.57% | 139,290 | 1.86B |
| 326 | APMD | Apnimed, Inc. | 1.55B | -1.89% | 60,207 | 120.15M |
| 327 | CNMD | CONMED Corporation | 1.54B | 0.37% | 43,401 | 1.37B |
| 328 | AAPG | Ascentage Pharma Group International | 1.54B | -0.98% | 377 | 94.61M |
| 329 | ARDT | Ardent Health, Inc. | 1.53B | 3.63% | 42,888 | 6.41B |
| 330 | INVA | Innoviva, Inc. | 1.52B | 0.48% | 76,513 | 440.00M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.52B | -0.40% | 60,485 | - |
| 332 | INBX | Inhibrx Biosciences, Inc. | 1.51B | 3.51% | 59,057 | 1.30M |
| 333 | SDGR | Schrรถdinger, Inc. | 1.51B | 2.86% | 376,479 | 259.04M |
| 334 | ENOV | Enovis Corporation | 1.50B | -0.42% | 84,521 | 2.30B |
| 335 | NVAX | Novavax, Inc. | 1.50B | 7.84% | 5,222,847 | 413.80M |
| 336 | INNV | InnovAge Holding Corp. | 1.50B | 2.75% | 126,980 | 949.17M |
| 337 | PAHC | Phibro Animal Health Corporation | 1.46B | 2.09% | 23,138 | 1.50B |
| 338 | OMDA | Omada Health, Inc. | 1.46B | 0.32% | 95,113 | 309.76M |
| 339 | ORIC | ORIC Pharmaceuticals, Inc. | 1.46B | 1.15% | 205,018 | - |
| 340 | ATEC | Alphatec Holdings, Inc. | 1.45B | 0.97% | 407,889 | 815.05M |
| 341 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -0.38% | 72,186 | - |
| 342 | SVRA | Savara Inc. | 1.41B | 1.28% | 427,853 | - |
| 343 | VOR | Vor Biopharma Inc. | 1.40B | 2.36% | 179,541 | - |
| 344 | OMER | Omeros Corporation | 1.40B | 3.49% | 713,670 | 38.42M |
| 345 | REPL | Replimune Group, Inc. | 1.39B | 5.27% | 916,342 | - |
| 346 | CGEM | Cullinan Therapeutics, Inc. | 1.39B | 0.98% | 406,853 | - |
| 347 | MNKD | MannKind Corporation | 1.38B | 0.94% | 823,915 | 393.63M |
| 348 | AORT | Artivion, Inc. | 1.38B | 1.25% | 80,090 | 471.47M |
| 349 | MGTX | MeiraGTx Holdings plc | 1.38B | -1.38% | 156,762 | 397.50M |
| 350 | JBIO | Jade Biosciences, Inc. | 1.38B | 1.98% | 188,668 | - |
| 351 | PNTG | The Pennant Group, Inc. | 1.36B | -0.08% | 39,455 | 1.10B |
| 352 | AKTS | Aktis Oncology, Inc. | 1.36B | 1.69% | 65,003 | 10.06M |
| 353 | AMN | AMN Healthcare Services, Inc. | 1.35B | 0.09% | 84,438 | 3.43B |
| 354 | DRTS | Alpha Tau Medical Ltd. | 1.35B | 1.67% | 231,526 | - |
| 355 | MLTX | MoonLake Immunotherapeutics | 1.35B | -0.25% | 222,881 | - |
| 356 | LTGO | Latigo Biotherapeutics, Inc. | 1.35B | -0.61% | 43,209 | - |
| 357 | ANRO | Alto Neuroscience, Inc. | 1.34B | -0.20% | 68,300 | - |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 2.06% | 24,476 | - |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.30B | 1.08% | 77,993 | 1.65B |
| 360 | CERT | Certara, Inc. | 1.30B | -2.23% | 433,944 | 421.75M |
| 361 | NUTX | Nutex Health Inc. | 1.29B | -0.02% | 38,505 | 846.72M |
| 362 | GLUE | Monte Rosa Therapeutics, Inc. | 1.27B | 0.41% | 186,318 | 28.73M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.23B | 3.76% | 169,901 | 337.34M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | 1.69% | 167,550 | - |
| 365 | IMTX | Immatics N.V. | 1.22B | 4.44% | 156,820 | 47.65M |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 1.22B | 3.24% | 29,148 | 99.00K |
| 367 | BVS | Bioventus Inc. | 1.21B | - | 133,442 | 581.85M |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.20B | -1.12% | 451,861 | 785.23M |
| 369 | SANA | Sana Biotechnology, Inc. | 1.19B | 6.55% | 1,389,576 | - |
| 370 | CRON | Cronos Group Inc. | 1.19B | 1.40% | 342,374 | 179.09M |
| 371 | TDOC | Teladoc Health, Inc. | 1.18B | -0.23% | 962,271 | 2.49B |
| 372 | STAA | STAAR Surgical Company | 1.16B | 0.52% | 102,420 | 339.59M |
| 373 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -0.71% | 47,031 | 804.27M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | -0.77% | 53,160 | 1.04B |
| 375 | IRMD | IRADIMED CORPORATION | 1.11B | 0.35% | 20,361 | 86.34M |
| 376 | OPK | OPKO Health, Inc. | 1.11B | 1.71% | 665,856 | 587.90M |
| 377 | IVA | Inventiva S.A. | 1.09B | 1.51% | 221,852 | 7.94M |
| 378 | GMRS | GMR Solutions Inc. | 1.08B | -1.94% | 110,156 | 5.88B |
| 379 | JANX | Janux Therapeutics, Inc. | 1.07B | 1.39% | 105,771 | 24.00M |
| 380 | KURA | Kura Oncology, Inc. | 1.06B | 2.05% | 561,261 | 77.23M |
| 381 | AVTX | Avalo Therapeutics, Inc. | 1.06B | -0.25% | 246,332 | 59.00K |
| 382 | WVE | Wave Life Sciences, Inc. | 1.06B | 2.29% | 645,623 | 65.37M |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.03B | 9.43% | 9,562,186 | 181.72M |
| 384 | QDEL | QuidelOrtho Corporation | 1.03B | 1.41% | 554,867 | 2.67B |
| 385 | CSTL | Castle Biosciences, Inc. | 1.03B | 2.03% | 117,602 | 357.28M |
| 386 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | 5.28% | 1,124,278 | 41.47M |
| 387 | GERN | Geron Corporation | 1.01B | 0.97% | 845,033 | 204.56M |
| 388 | SLDB | Solid Biosciences Inc. | 1.00B | 2.97% | 232,460 | - |
| 389 | CLYM | Climb Bio, Inc. | 995.37M | 1.82% | 169,005 | - |
| 390 | CADL | Candel Therapeutics, Inc. | 987.85M | 4.53% | 469,589 | - |
| 391 | ARDX | Ardelyx, Inc. | 980.55M | 0.90% | 758,032 | 450.89M |
| 392 | ANNX | Annexon, Inc. | 973.49M | -0.87% | 455,022 | - |
| 393 | IMMX | Immix Biopharma, Inc. | 971.50M | 3.19% | 543,556 | - |
| 394 | DSGN | Design Therapeutics, Inc. | 967.51M | -0.64% | 255,816 | - |
| 395 | OLMA | Olema Pharmaceuticals, Inc. | 961.26M | 0.79% | 222,362 | - |
| 396 | PCRX | Pacira BioSciences, Inc. | 947.92M | -0.21% | 60,287 | 746.16M |
| 397 | ACRS | Aclaris Therapeutics, Inc. | 942.07M | 1.11% | 396,770 | 8.22M |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 929.88M | 0.83% | 56,945 | 730.02M |
| 399 | CBLL | CeriBell, Inc. | 922.61M | -1.11% | 90,733 | 101.96M |
| 400 | ANL | Adlai Nortye Ltd. | 906.40M | 2.59% | 32,465 | 18.06M |
| 401 | SGP | SpyGlass Pharma, Inc. | 890.89M | 1.54% | 14,228 | - |
| 402 | AVR | Anteris Technologies Global Corp. | 890.77M | -1.19% | 147,662 | 2.24M |
| 403 | COLL | Collegium Pharmaceutical, Inc. | 883.23M | -1.49% | 101,608 | 808.21M |
| 404 | SIBN | SI-BONE, Inc. | 882.93M | 1.13% | 495,343 | 213.60M |
| 405 | TBPH | Theravance Biopharma, Inc. | 881.32M | 0.15% | 175,186 | 104.31M |
| 406 | FDMT | 4D Molecular Therapeutics, Inc. | 880.04M | -1.06% | 296,715 | 92.01M |
| 407 | ATTO | Attovia Therapeutics, Inc. | 877.79M | 0.94% | 101,073 | 1.35M |
| 408 | GLAS | Glass House Brands Inc. | 877.09M | 2.73% | 50,333 | 164.83M |
| 409 | INMD | InMode Ltd. | 865.66M | 0.94% | 63,161 | 374.63M |
| 410 | OBX | Obsidian Therapeutics, Inc. | 863.49M | -1.29% | 838,800 | - |
| 411 | DBVT | DBV Technologies S.A. | 861.96M | 1.26% | 70,591 | 5.04M |
| 412 | RIGL | Rigel Pharmaceuticals, Inc. | 858.34M | 1.55% | 46,741 | 276.79M |
| 413 | BBNX | Beta Bionics, Inc. | 851.20M | -2.87% | 150,037 | 119.01M |
| 414 | AHG | Akso Health Group | 843.85M | -3.43% | 1,487 | 13.83M |
| 415 | HSTM | HealthStream, Inc. | 831.58M | -0.52% | 55,161 | 321.12M |
| 416 | ACHV | Achieve Life Sciences, Inc. | 828.37M | 0.37% | 244,871 | - |
| 417 | PHAR | Pharming Group N.V. | 822.85M | 2.14% | 8,872 | 366.48M |
| 418 | FTH | Faeth Therapeutics, Inc. | 821.47M | -0.97% | 136,958 | - |
| 419 | AURA | Aura Biosciences, Inc. | 817.71M | 1.48% | 168,250 | - |
| 420 | OCS | Oculis Holding AG | 813.01M | 0.23% | 9,110 | 1.45M |
| 421 | HELP | Cybin Inc. | 800.83M | 3.61% | 849,003 | - |
| 422 | SLN | Silence Therapeutics plc | 790.55M | -0.30% | 65,703 | 615.00K |
| 423 | DRUG | Bright Minds Biosciences Inc. | 783.53M | -1.46% | 71,217 | - |
| 424 | VREX | Varex Imaging Corporation | 779.32M | - | 198,943 | 865.00M |
| 425 | NGNE | Neurogene Inc. | 757.83M | -0.32% | 24,473 | 925.00K |
| 426 | NVCT | Nuvectis Pharma, Inc. | 745.66M | -1.99% | 64,701 | - |
| 427 | PHR | Phreesia, Inc. | 745.45M | 0.50% | 137,140 | 495.59M |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 740.41M | 1.71% | 42,541 | - |
| 429 | AHCO | AdaptHealth Corp. | 735.08M | 2.23% | 388,826 | 3.36B |
| 430 | GYRE | Gyre Therapeutics, Inc. | 734.81M | -1.28% | 21,698 | 109.82M |
| 431 | MNPR | Monopar Therapeutics Inc. | 733.24M | -1.48% | 60,780 | - |
| 432 | STTK | Shattuck Labs, Inc. | 729.64M | 0.28% | 77,729 | 1.00M |
| 433 | TECX | Tectonic Therapeutic, Inc. | 727.82M | 3.27% | 36,341 | - |
| 434 | CTMX | CytomX Therapeutics, Inc. | 727.78M | 1.52% | 596,879 | 18.30M |
| 435 | ALLO | Allogene Therapeutics, Inc. | 727.26M | 0.24% | 1,580,885 | 4.64M |
| 436 | CBIO | Crescent Biopharma, Inc. | 719.49M | 3.57% | 116,961 | 11.88M |
| 437 | RGNX | REGENXBIO Inc. | 716.24M | -1.90% | 309,073 | 174.48M |
| 438 | SOPH | SOPHiA GENETICS SA | 714.22M | 0.72% | 82,306 | 86.17M |
| 439 | ZVRA | Zevra Therapeutics, Inc. | 709.04M | 0.42% | 130,757 | 136.07M |
| 440 | ASMB | Assembly Biosciences, Inc. | 707.63M | 3.65% | 157,374 | 74.85M |
| 441 | SSII | SS Innovations International, Inc. | 703.35M | -2.77% | 31,406 | 52.40M |
| 442 | EVO | Evotec SE | 696.71M | -1.02% | 31,098 | 819.47M |
| 443 | PHAT | Phathom Pharmaceuticals, Inc. | 695.81M | 1.86% | 227,846 | 239.66M |
| 444 | IRWD | Ironwood Pharmaceuticals, Inc. | 695.66M | 1.69% | 349,949 | 389.32M |
| 445 | PRLD | Prelude Therapeutics Incorporated | 680.80M | 1.69% | 205,499 | 22.42M |
| 446 | KIDS | OrthoPediatrics Corp. | 667.24M | -2.57% | 32,521 | 252.72M |
| 447 | STLN | Starling Oncology, Inc. | 662.45M | -0.61% | 420,303 | 587.24M |
| 448 | TLRY | Tilray Brands, Inc. | 661.80M | 4.50% | 2,191,142 | 915.45M |
| 449 | SCTX | Scribe Therapeutics Inc. | 657.61M | 6.18% | 82,163 | 36.28M |
| 450 | AGMB | AgomAb Therapeutics NV | 655.98M | -0.82% | 4,441 | - |
| 451 | OABI | OmniAb, Inc. | 654.26M | 4.65% | 674,043 | 38.46M |
| 452 | VALN | Valneva SE | 648.10M | 3.08% | 10,628 | 163.30M |
| 453 | ANGO | AngioDynamics, Inc. | 648.09M | -0.88% | 30,508 | 320.17M |
| 454 | CRMD | CorMedix Inc. | 643.04M | 0.24% | 261,211 | 462.25M |
| 455 | EIKN | Eikon Therapeutics, Inc. | 642.94M | 10.42% | 147,375 | - |
| 456 | AUTL | Autolus Therapeutics plc | 642.78M | -1.83% | 1,234,957 | 117.39M |
| 457 | SGMT | Sagimet Biosciences Inc. | 642.72M | 1.57% | 284,388 | - |
| 458 | MDXG | MiMedx Group, Inc. | 631.14M | 0.70% | 195,230 | 355.17M |
| 459 | VSTM | Verastem, Inc. | 628.51M | 1.76% | 270,040 | 87.53M |
| 460 | CTNM | Contineum Therapeutics, Inc. | 621.50M | 3.12% | 47,178 | - |
| 461 | ALT | Altimmune, Inc. | 620.51M | 8.14% | 2,916,386 | 31.00K |
| 462 | CTKB | Cytek Biosciences, Inc. | 614.82M | 1.50% | 105,276 | 206.71M |
| 463 | PRME | Prime Medicine, Inc. | 610.21M | 5.86% | 1,315,877 | 4.07M |
| 464 | BWAY | BrainsWay Ltd. | 609.52M | -1.34% | 8,386 | 60.70M |
| 465 | CTEV | Claritev Corporation | 608.07M | 5.28% | 17,932 | 994.67M |
| 466 | ARVN | Arvinas, Inc. | 607.44M | 2.94% | 141,757 | 316.70M |
| 467 | DCTH | Delcath Systems, Inc. | 587.45M | 1.07% | 67,875 | 95.42M |
| 468 | WEAV | Weave Communications, Inc. | 584.39M | 0.21% | 1,324,072 | 257.79M |
| 469 | AQST | Aquestive Therapeutics, Inc. | 582.37M | 3.23% | 770,262 | 54.09M |
| 470 | ENTX | Entera Bio Ltd. | 567.91M | 1.86% | 81,195 | 42.00K |
| 471 | CERS | Cerus Corporation | 564.27M | 0.36% | 583,310 | 221.55M |
| 472 | ARTV | Artiva Biotherapeutics, Inc. | 559.79M | 2.78% | 46,961 | 251.00K |
| 473 | ZURA | Zura Bio Limited | 556.77M | 1.04% | 156,669 | - |
| 474 | CABA | Cabaletta Bio, Inc. | 554.41M | 2.51% | 1,829,180 | - |
| 475 | SPRY | ARS Pharmaceuticals, Inc. | 551.93M | 0.82% | 344,980 | 116.93M |
| 476 | EOLS | Evolus, Inc. | 549.21M | -0.42% | 85,341 | 316.49M |
| 477 | FLGT | Fulgent Genetics, Inc. | 547.83M | -0.05% | 61,651 | 323.93M |
| 478 | OVID | Ovid Therapeutics Inc. | 544.88M | 1.82% | 320,891 | 1.58M |
| 479 | SRTA | Strata Critical Medical, Inc. | 541.42M | 2.68% | 352,395 | 255.98M |
| 480 | TCMD | Tactile Systems Technology, Inc. | 531.88M | 0.21% | 79,336 | 350.31M |
| 481 | EVH | Evolent Health, Inc. | 531.38M | - | 632,982 | 2.10B |
| 482 | RZLT | Rezolute, Inc. | 527.03M | 8.26% | 3,018,261 | - |
| 483 | MPLT | MapLight Therapeutics, Inc. | 517.11M | -0.71% | 66,965 | - |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 516.39M | 2.71% | 195,113 | - |
| 485 | EVMN | Evommune, Inc. | 511.36M | 3.83% | 92,912 | 10.00M |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 487 | SENS | Senseonics Holdings, Inc. | 501.77M | 7.60% | 448,171 | 48.55M |
| 488 | RLMD | Relmada Therapeutics, Inc. | 490.15M | -0.97% | 300,672 | - |
| 489 | BLSM | BlossomHill Therapeutics, Inc. | 489.69M | 1.14% | 11,798 | - |
| 490 | NRC | NRC Health | 488.84M | 1.28% | 19,783 | 140.00M |
| 491 | CCCC | C4 Therapeutics, Inc. | 485.95M | -1.99% | 268,683 | 35.04M |
| 492 | DNA | Ginkgo Bioworks Holdings, Inc. | 483.50M | 3.16% | 504,729 | 132.42M |
| 493 | NPCE | NeuroPace, Inc. | 482.60M | 0.29% | 34,392 | 106.99M |
| 494 | PBYI | Puma Biotechnology, Inc. | 478.00M | 1.65% | 69,859 | 231.24M |
| 495 | PRTA | Prothena Corporation plc | 477.43M | 2.99% | 61,872 | 54.53M |
| 496 | OCGN | Ocugen, Inc. | 476.45M | 1.08% | 696,855 | 4.58M |
| 497 | EDIT | Editas Medicine, Inc. | 476.10M | 5.44% | 1,223,793 | 47.01M |
| 498 | QTTB | Q32 Bio Inc. | 474.82M | 0.57% | 81,678 | 53.74M |
| 499 | CLPT | ClearPoint Neuro, Inc. | 470.99M | 1.65% | 123,378 | 42.28M |
| 500 | PROK | ProKidney Corp. | 468.60M | 9.15% | 932,240 | 818.00K |